Ductal Carcinoma In Situ: Biology, Diagnosis, and New Therapies
- 1 August 2007
- journal article
- review article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 7 (9), 16-21
- https://doi.org/10.3816/cbc.2007.n.026
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Novel Clinical Trial Designs for Treatment of Ductal Carcinoma In Situ of the Breast with Trastuzumab (Herceptin)The Breast Journal, 2007
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy GroupJournal of Clinical Oncology, 2006
- Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance ImagingThe Breast Journal, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerThe New England Journal of Medicine, 2002
- Tumour markers in breast carcinoma correlate with grade rather than with invasivenessBritish Journal of Cancer, 2001
- Ductal carcinoma in situ of the breast: the clinical significance of histological classificationHistopathology, 1997
- Clustered Breast Microcalcifications: Evaluation by Dynamic Contrast-Enhanced Subtraction MRIJournal of Computer Assisted Tomography, 1996
- Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situBreast Cancer Research and Treatment, 1991
- Noninvasive Breast CarcinomaAnnals of Surgery, 1980